Search Results for: Xenazine

Physical Therapy and Huntington’s Disease

The hallmark of Huntington’s disease is difficulty with both involuntary movement, such as reflexes, and voluntary movement, such as walking. An example of an involuntary movement problem is akathisia, or ... Read more

Triheptanoin

Triheptanoin (also known as C7 oil) is an investigational medical food or supplement being developed by Inserm Tranfert, Ultragenyx Pharmaceutical, and ICM (the Brain and Spinal Cord Institute). It aims ... Read more

Huntexil (Pridopidine)

Huntexil (pridopidine) is an investigational oral dopamine stabilizer that Teva Pharmaceuticals is developing to possibly treat symptoms of Huntington’s disease. How Huntexil works It is a dopamine stabilizer. These are molecules that bind to the ... Read more

Treatment for Huntington’s Disease

Scientists have yet to develop a cure for Huntington’s disease or a treatment that can stop its progression. But there are treatments that can help patients manage their symptoms, which ... Read more

Deutetrabenazine (Austedo)

The U.S. Food and Drug Administration (FDA) approved Austedo (deutetrabenazine) in 2017 for the treatment of chorea associated with Huntington’s disease (HD), according to a press release from its maker, Teva. Chorea is ... Read more